Intra-Cellular Therapies, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ALKS
|
Alkermes plc | $27.54 | $4.05 B | 7.12 | 2100 | $1.66 B |
 AMPH
|
Amphastar Pharmaceuticals, Inc. | $44.18 | $1.99 B | 13.99 | 1761 | $644.40 M |
 AMRX
|
Amneal Pharmaceuticals, Inc. | $8.34 | $2.08 B | -9.25 | 7850 | $2.39 B |
 ANIP
|
ANI Pharmaceuticals, Inc. | $55.30 | $1.40 B | 41.45 | 642 | $486.82 M |
 AQST
|
Aquestive Therapeutics, Inc. | $4.65 | $250.36 M | -6.11 | 135 | $50.58 M |
 COLL
|
Collegium Pharmaceutical, Inc. | $29.21 | $1.09 B | 13.22 | 197 | $566.77 M |
 CYTH
|
Cyclo Therapeutics, Inc. | $0.72 | $36.06 M | -1.37 | 8 | $1.08 M |
 DCPH
|
Deciphera Pharmaceuticals, Inc. | $25.59 | $2.21 B | -11.57 | 355 | $163.36 M |
 DVAX
|
Dynavax Technologies Corporation | $11.69 | $1.58 B | 172.29 | 408 | $232.28 M |
 EGRX
|
Eagle Pharmaceuticals, Inc. | $0.90 | $48.18 M | 4.36 | 134 | $316.61 M |
 IRWD
|
Ironwood Pharmaceuticals, Inc. | $4.02 | $1.01 B | -0.94 | 267 | $442.74 M |
 NBIX
|
Neurocrine Biosciences, Inc. | $117.67 | $13.58 B | 36.58 | 1700 | $1.89 B |
 PCRX
|
Pacira BioSciences, Inc. | $16.67 | $1.33 B | 18.92 | 711 | $674.98 M |